GGI
CVS icon

Godsey & Gibb Inc’s CVS Health CVS Stock Holding History

Godsey & Gibb Inc’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20
Closed -$1.59K – 402
2025
Q4 		$1.59K Buy
+20
New +$1.58K ﹤0.01% 401
2024
Q3 		– Sell
-166
Closed -$9.8K – 438
2024
Q2 		$9.8K Sell
166
-133
-44% -$8.32K ﹤0.01% 303
2024
Q1 		$23.8K Sell
299
-29
-9% -$2.21K ﹤0.01% 211
2023
Q4 		$25.9K Sell
328
-430
-57% -$30.6K ﹤0.01% 202
2023
Q3 		$52.9K Buy
758
+459
+154% +$32.5K 0.01% 153
2023
Q2 		$20.7K Buy
299
+99
+50% +$7.04K ﹤0.01% 220
2023
Q1 		$14.9K Sell
200
-100
-33% -$8.39K ﹤0.01% 221
2022
Q4 		$28K Buy
+300
New +$28.9K 0.01% 147
2018
Q2 		– Sell
-116
Closed -$7K – 69
2018
Q1 		$7K Buy
+116
New +$8.32K ﹤0.01% 67

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Godsey & Gibb Inc's CVS Position: Q1 2026 in Review

Godsey & Gibb Inc sold out of CVS Health (CVS) in Q1 2026, closing a stake of 20 shares — an estimated $1.59K sold.

Godsey & Gibb Inc first reported a position in CVS in Q1 2018 and held it in 9 quarters. The position peaked at $52.9K in Q3 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Godsey & Gibb Inc reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Godsey & Gibb Inc sold 20 CVS Health shares in Q1 2026, an estimated $1.59K.
  • Godsey & Gibb Inc first reported a position in CVS Health in Q1 2018 and held it in 9 quarters.
  • Godsey & Gibb Inc's CVS Health position peaked at $52.9K in Q3 2023.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Godsey & Gibb Inc's 13F filing for Q1 2026, filed 20 Apr 2026.